Sign in

CIK 0001745999 · Large accelerated filer

Beam Therapeutics Inc.

Sign in to watch
Ticker
BEAM
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
FY end
Dec 31
Incorporated
DE
Entity type
operating
Phone
857-327-8775
Business address
26 LANDSDOWNE STREET, CAMBRIDGE, MA, 02139
Former names
Beam Therapeutics Inc.
  1. 4 Open-market sale CFO sold 1,787 shares at $59.11 ($105,630)
  2. S-8 Other Securities Offered to Employees in Benefit Plans
  3. 10-K Report Annual Report
  4. 8-K Event Results of operations
  5. SC 13G/A Stake Amended Statement of Ownership
  6. SC 13G/A Stake Amended Statement of Ownership
  7. SC 13G/A Stake Amended Statement of Ownership
  8. SC 13G/A Stake Amended Statement of Ownership
  9. SC 13G Stake Amended Statement of Ownership
  10. SC 13G/A Stake Amended Statement of Ownership
  11. SC 13G/A Stake Amended Statement of Ownership
  12. SC 13G Stake Amended Statement of Ownership
  13. 4 Derivatives Options or other derivatives
  14. 4/A Open-market sale CEO sold 50,000 shares at an average $66.84 ($3,341,903)
  15. 4 Derivatives Options or other derivatives
  16. 3 Insider Initial Statement of Ownership
  17. SC 13G/A Stake Amended Statement of Ownership
  18. 8-K Event Results of operations · Regulation FD disclosure · Other events
  19. 4 Option exercise President & CSO acquired 39,700 shares (option exercise)
  20. 4 Open-market sale President & CSO sold 2,607 shares at an average $86.13 ($224,531)

Page 18 of 26 · 514 filings